Non-HLA Autoantibody-Driven Lung Allograft Injury, Clinical Course, Autoantibody Profiling, and Response to Steroid and Belatacept
The presence of HLA donor-specific antibodies (DSAs), both before and after transplantation, is a well-established risk factor for antibody-mediated rejection (AMR) and poor graft survival. However, emerging evidence suggests that non-HLA antibodies may also provoke immune responses, contributing to rejection. Among th...